Harmony Biosciences Management, Inc.

This study looked at the long-term safety and effectiveness of pitolisant in 119 adults with idiopathic hypersomnia, a condition causing excessive daytime sleepiness. Participants had already completed a previous study. The goal was to see if pitolisant remains safe and helps red…

This study tested a gel called ZYN002, applied to the skin, in 20 children and teens (ages 4 to 17) with 22q11.2 deletion syndrome. The main goal was to see if the gel is safe and tolerable over 38 weeks. Researchers also looked at whether it could help with behavioral symptoms. …

This study tested a new delayed-release version of the drug pitolisant (HBS-201) in 46 adults with narcolepsy. The goal was to see if starting at a full therapeutic dose is safe and tolerable. Researchers measured how many people stopped treatment due to side effects and tracked …

This study looked at how a gel called ZYN002 affects the way the body processes other drugs. Twenty-nine healthy adults took ZYN002 along with several common medications. Researchers measured drug levels in blood and urine to see if ZYN002 changed how those drugs work. The goal w…